Download A4Medicine Mobile App

Empower Your RCGP AKT Journey: Master the MCQs with Us! 🚀

A4Medicine

Cervical Screening

Cervical screening plays a crucial role in the early detection and prevention of cervical cancer. In England, Wales, Scotland, and Northern Ireland, the approach to cervical screening has evolved, with HPV primary screening becoming the standard practice.


This approach involves testing cervical cells for the presence of the human papillomavirus (HPV), a known risk factor for cervical cancer. In this introduction, we will explore key aspects of HPV primary screening, including the target population, the conditions screened for, the screening process, and its significance, especially for vaccinated individuals. Understanding the principles of HPV primary screening is essential for individuals eligible for cervical screening and healthcare providers alike.



AspectDetails
Target PopulationWomen and people with a cervix aged 25 to 64 in England.

Eligible individuals registered with a GP (as female) receive invitations by mail.

Trans men (assigned female at birth) can still get screening if they have a cervix.

The first invitation is sent at the age of 24.5 years.

Ages 25 to 49 receive invitations every 3 years.

Ages 50 to 64 receive invitations every 5 years.
Condition Screened ForCervical screening looks for the human papillomavirus (HPV), which can cause abnormal cells on the cervix. If HPV...

Try our Free Plan to get the full article.